| Literature DB >> 24853806 |
Qingming Dong1, Francesco Giorgianni2, Xiong Deng3, Sarka Beranova-Giorgianni2, Dave Bridges4, Edwards A Park1, Rajendra Raghow3, Marshall B Elam5.
Abstract
The counter-regulatory hormone glucagon inhibits lipogenesis via downregulation of sterol regulatory element binding protein 1 (SREBP-1). The effect of glucagon is mediated via protein kinase A (PKA). To determine if SREBP-1 is a direct phosphorylation target of PKA, we conducted mass spectrometry analysis of recombinant n-terminal SREBP-1a following PKA treatment in vitro. This analysis identified serines 331/332 as bona-fide phosphorylation targets of PKA. To determine the functional consequences of phosphorylation at these sites, we constructed mammalian expression vector for both nSREBP-1a and 1c isoforms in which the candidate PKA phosphorylation sites were mutated to active phosphomimetic or non-phosphorylatable amino acids. The transcriptional activity of SREBP was reduced by the phosphomimetic mutation of S332 of nSREBP-1a and the corresponding serine (S308) of nSREBP-1c. This site is a strong candidate for mediating the negative regulatory effect of glucagon on SREBP-1 and lipogenesis. Published by Elsevier Inc.Entities:
Keywords: Immobilized metal affinity chromatography (IMAC); Mass spectrometry (MS); Phosphorylation; Protein kinase A (PKA); Site-directed mutagenesis; Sterol regulatory element binding protein (SREBP)
Mesh:
Substances:
Year: 2014 PMID: 24853806 PMCID: PMC4670028 DOI: 10.1016/j.bbrc.2014.05.046
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575